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Evolutionary approaches are particularly valuable for studies of sexually transmitted diseases. Methods for tracing
evolutionary phylogenies have powerful new applications that use genetic data to trace the history of pathogens
across millions of years, within outbreaks lasting years, and even within individuals. Equally valuable are less widely
appreciated evolutionary methods for analyzing how host–pathogen co-evolution shapes extreme traits whose costs
can be substantial. These and other applications of Darwinian medicine will improve understanding and treatment
of sexually transmitted diseases.
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The vast majority of studies on sexually transmit-
ted infections (STI) has focused on diagnosis, treat-
ment (especially emerging antibiotic resistance),
and pathogenesis. In recent years, evolutionary ap-
proaches to medicine and public health have sug-
gested new questions with new answers about these
and other aspects of STI.1–4 Two kinds of evolution-
ary explanations have proved particularly valuable.
The first, explanations of phylogeny and origins, has
been the focus of excellent work on sexually trans-
mitted infections (STIs). The second, equally valu-
able, are analyses of how coevolution of pathogens
and hosts explains specialized traits and patterns of
virulence and trends in antibiotic resistance.
Phylogenetic studies have led to several general
conclusions. First, sexually transmitted pathogens
are nothing new; they have been interacting with
hosts in nearly all species, including plants, for
eons.5 Second, it is clear that organisms often make
the transition from nongenital to genital transmis-
sion, and after this transition, new selection forces
shape them and their hosts. The result is extraor-
dinary pathogen specialization for sexual transmis-
sion and delicacy outside the protected genital niche.
In conjunction with the new availability of ge-
netic data, phylogenetic methods have also made
it possible to trace the origins of specific strains
of pathogens in both long and short time frames,
with more progress coming fast. The case of HIV
is a dramatic exemplar, but many pathogens can
now be traced with enormous specificity, enhanc-
ing outbreak investigations and providing insight
into pathogen emergence and spread. In combina-
tion with evolutionary theory, molecular methods
are proving crucial for epidemiology.6
The other less-recognized contribution of evolu-
tionary biology is an analysis of the selection forces
shaping sexually transmitted pathogens in cycle af-
ter cycle of host–parasite coevolution that makes
them very special indeed.5,7,8 This is the realm of
behavioral ecology, where every trait is analyzed in
terms of trade-offs—the costs and benefits of vari-
ations.9 This perspective offers many opportunities
for progress, albeit with methods less straightfor-
ward than those using genetic data to analyze phylo-
genies. It makes possible analysis of the adaptations
of sexually transmitted organisms to their specific
niche, with the attendant costs and benefits of those
specializations. It also gives insight into how STIs
can change behavior and even sex ratios.
For example, a sexually transmitted insect
pathogen, Wolbachia, uses several strategies to in-
crease the number of infected females in the popula-
tion, including feminization, parthenogenesis, male
killing, and sperm–egg incompatibility.10 Sperm
from an infected male does not result in offspring
unless the female is infected with the same strain
of Wolbachia.11 Lest we believe humans are im-
mune to such manipulation, some bacterial STIs
(e.g., chlamydia and gonorrhea) cause infertility.
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Infertility has profound effects on population struc-
ture.12 It may also motivate seeking additional part-
ners, thus spreading disease. Furthermore, in the
not so distant past, a recommended cure for sex-
ually transmitted diseases was to have sex with a
virgin.13 Although we know that humans with STIs
have a history of more sex partners, it is uncertain
if STIs might increase mating frequency.
Organisms transmitted by sexual contact are
shaped by innumerable cycles of host–pathogen co-
evolution. They develop specialized mechanisms for
invading genital mucosa, but become delicate out-
side of the genital niche. The density of the host
population is relatively less important for trans-
mission than frequency of sexual contact.5 When
frequency of mating is low, this selects for low vir-
ulence, causing chronic disease, although increased
rates of contact may shape higher virulence.5,14–16
Scientists are increasingly taking the pathogen’s
point of view when analyzing interactions with
hosts. This change in perspective brings needed at-
tention to the complexities of coevolution and the
profound impact of changes in the ecosystem. This
is particularly relevant for STIs now, as our immune
systems have been substantially modified from those
of our ancestors as a result of changes in diet and
antibiotics that change our microbiomes.17 Changes
in exposure to helminths and other pathogens also
change our immune systems so that inflammatory
responses to certain stimuli are orders of magnitude
higher than humans experienced prior to modern-
ization. An evolutionary approach to trade-offs in
immune responses is also developing quickly, with
recognition that the substantial costs of inflamma-
tion exist because in the ancestral environment they
give, on average, a net benefit in the long run. In the
modern environment, the optimal amount of in-
flammation may be quite different, an opportunity
for study with practical implications.18
Research into selection on behavior has begun,
and yielded remarkably few behavioral adaptations
to avoid STI acquisition. Primates in species espe-
cially subject to STIs do not inspect sexual partners
more carefully, nor are they more choosy, although
the effect of STIs on selection is confirmed by their
higher white blood cell counts.19 The absence of
behavioral adaptations to avoid infection is surpris-
ing and requires further investigation. One possi-
ble explanation is that dangerous partners are not
readily identified, perhaps because pathogen strains
are shaped to be covert; gonorrhea and chlamydia
are frequently asymptomatic or cause only minor
symptoms. It is also possible that the reproductive
benefits of sex now are usually greater than the pos-
sible future costs of contracting a STI. However,
20–30% of women cannot conceive because of dam-
age from STI in some areas where infections are
prevalent. This would seem to create an enormous
selection force that should have major effects on
behavioral tendencies as well as immune function.
Looking for such effects offers a fine opportunity for
research.
Many scientists are using evolutionary ideas to
understand how selection changes organisms. How-
ever, selection far more often keeps things the same.
Every trait has a distribution, and individuals at the
extremes usually have reproductive success lower
than those in the middle. This applies to the inten-
sity of the inflammatory response, the allocation of
resources to immune defenses versus other invest-
ments, and it applies to sexual behavior tendencies.
Looking carefully at the reproductive success of in-
dividuals at the extremes of relevant traits offers a
substantial opportunity. This applies, of course, to
pathogens as well as hosts. Because the generation
time for most pathogens is much shorter than the
human lifespan (e.g., 30 min for Escherichia coli), a
five-day course of antibiotics may allow only resis-
tant pathogens to survive, and some of those may
have evolved ways to minimize the fitness costs of
resistance mechanisms. Modern laboratory tech-
niques can distinguish between de novo resistant
mechanisms that arise following therapy from selec-
tion for an existing mutation or following the spread
of a resistance mutation via recombination or hor-
izontal gene transfer; however, interpreting the re-
sults and predicting emergence and spread requires
theory. Evolutionary theory offers our best hope of
using results of these analyses to keep a distance
between ourselves and faster evolving pathogens.20
Evolutionary medicine emphasizes the role of
changing environments and fast-evolving patho-
gens as two of six factors that need consideration
when trying to explain vulnerability to disease; other
factors include constraints on selection, tradeoffs,
selection for reproduction at the cost of health, and
the costs of defenses such as inflammation.2 All six
factors could be approached systematically in re-
search on STIs.
Research on the effects of changes in the micro-
biota, and changes in immune responses as a result
of deficient early exposure to immune stimulation,
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is underway. For example, we already know that the
presence of bacterial vaginosis, a condition char-
acterized by a disrupted microbial community, is
associated with an increased risk of acquiring and
transmitting HIV. Genital herpes infection also in-
creases rates of HIV acquisition and transmission.21
Further research is urgently needed, because chang-
ing sexual behaviors are changing transmission dy-
namics in ways that will shape certain pathogens for
faster transmission. This is particularly the case for
transmission of herpes viruses in response to recent
increases in oral–genital sex.
The effects of vaccines as a force of selection
are also on the radar, but they could be addressed
more explicitly. Research showing that vaccination
for Marek’s disease in chickens resulted in increased
virulence of this viral pathogen suggests the need
for systematic research.22 This is being considered
by epidemiologists who are watching changes in
human papilloma virus because of vaccination. It
would be tragic if we did not take full advantage
of our knowledge of how vaccination can be a se-
lection force to try to anticipate and avoid public
health problems.
Curiously, one of the foundations of evolutionary
understanding of sex remains uncertain.23–25 Sexual
reproduction passes on only half as many of a fe-
male’s genes as nonsexual reproduction. You would
think that asexual clades would soon displace sexual
ones. That is exactly what happens in lizards that
evolve through asexual reproduction. Sex persists,
however, in large part because of selection pressures
from infectious disease. In the field, this is observed
in population crashes in asexual clades, which, being
genetically identical, are prone to being wiped out by
a pathogen. Thus, sex protects us against infection,
even as it makes us vulnerable. We anticipate much
will come from the synthesis of evolution, epidemi-
ology, and molecular methods applied to the study
of sexually transmitted infections.
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